Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

NCT04462614 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT04462614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04462614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA
Lead sponsor
CHU de Reims
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2020
Completion date
July 31, 2021
Enrollment
49 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants / administration & dosage, biocompatible, chronic hemolysis, coated materials, heparin / administration & dosage, membranes artificial, prospective studies, renal dialysis / methods, renal insufficiency / therapy, vka